N,5-Dimethoxy-N-methylnicotinamide

Catalog No. :
ACMPEY762
CAS No. :
1045855-73-9
Molecular Formula :
C9H12N2O3
Molecular Weight :
196.21

IUPAC Name:N,5-dimethoxy-N-methylnicotinamide

N,5-Dimethoxy-N-methylnicotinamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg97%$80.00Login to see priceIn stockIn stock
250mg97%$138.00Login to see priceIn stockIn stock
1g97%$436.00Login to see priceIn stockIn stock
5g97%$1400.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN,5-Dimethoxy-N-methylnicotinamide
IUPAC NameN,5-dimethoxy-N-methylnicotinamide
MDL No.MFCD11052849
Molecular FormulaC9H12N2O3
Molecular Weight196.21
SMILESO=C(N(OC)C)C1=CN=CC(OC)=C1
InChI KeyWUSBOFJJDWHGCK-UHFFFAOYSA-N
SynonymN,5-Dimethoxy-N-methylnicotinamide | 1045855-73-9 | N,5-dimethoxy-N-methylpyridine-3-carboxamide | DTXSID40670125 | VRB85573 | MFCD11052849 | AKOS006308935 | CS-0440220 | FT-0716795 | F84159 | N,5-Dimethoxy-N-methylnicotinamide, AldrichCPR
CAS No.1045855-73-9
PubChem CID45361744

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302
Precautionary Statement(s)
P280-P305+P351+P338

Synthetic Route by SureRoute

1. ACMPEY762 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACCLNE518 route compound structure diagram
    ACCLNE5186638-79-5 In Stock
  2. Plus
  3. ACBYQE761 route compound structure diagram
    ACBYQE76120826-03-3 In Stock
  4. Then
  5. ACMPEY762 route product structure diagram
    ACMPEY7621045855-73-9 In Stock
Inquiry

2. ACMPEY762 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACCLNE518 route compound structure diagram
    ACCLNE5186638-79-5 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACMPEY762 route product structure diagram
    ACMPEY7621045855-73-9 In Stock
Inquiry

Comments (0)